Pancreatic cancer patient Ben Sasse sees 'massive' tumor reduction with experimental new drug
Summary
Former Nebraska Sen. Ben Sasse said the experimental drug daraxonrasib has dramatically reduced his pancreatic tumors. Trial data suggests the therapy doubles s...
Description
Former Nebraska Sen. Ben Sasse said the experimental drug daraxonrasib has dramatically reduced his pancreatic tumors. Trial data suggests the therapy doubles s...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source